Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · IEX Real-Time Price · USD
68.28
+0.53 (0.78%)
Jul 2, 2024, 4:00 PM EDT - Market closed
PBH Revenue
In the fiscal year ending March 31, 2024, Prestige Consumer Healthcare had annual revenue of $1.13B, a decrease of -0.21%. Revenue in the quarter ending March 31, 2024 was $276.99M, a -3.11% decrease year-over-year.
Revenue (ttm)
$1.13B
Revenue Growth
-0.21%
P/S Ratio
3.01
Revenue / Employee
$2,009,566
Employees
560
Market Cap
3.39B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1.13B | -2.37M | -0.21% |
Mar 31, 2023 | 1.13B | 40.91M | 3.76% |
Mar 31, 2022 | 1.09B | 143.45M | 15.21% |
Mar 31, 2021 | 943.37M | -19.65M | -2.04% |
Mar 31, 2020 | 963.01M | -12.77M | -1.31% |
Mar 31, 2019 | 975.78M | -65.40M | -6.28% |
Mar 31, 2018 | 1.04B | 159.12M | 18.04% |
Mar 31, 2017 | 882.06M | 75.81M | 9.40% |
Mar 31, 2016 | 806.25M | 91.62M | 12.82% |
Mar 31, 2015 | 714.62M | 117.24M | 19.63% |
Mar 31, 2014 | 597.38M | -22.74M | -3.67% |
Mar 31, 2013 | 620.12M | 179.03M | 40.59% |
Mar 31, 2012 | 441.09M | 104.58M | 31.08% |
Mar 31, 2011 | 336.51M | 43.91M | 15.01% |
Mar 31, 2010 | 292.60M | -1.74M | -0.59% |
Mar 31, 2009 | 294.35M | -20.76M | -6.59% |
Mar 31, 2008 | 315.11M | -3.53M | -1.11% |
Mar 31, 2007 | 318.63M | 21.97M | 7.40% |
Mar 31, 2006 | 296.67M | 7.60M | 2.63% |
Mar 31, 2005 | 289.07M | 217.34M | 302.97% |
Mar 31, 2003 | 71.73M | 25.53M | 55.27% |
Mar 31, 2002 | 46.20M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Oscar Health | 6.54B |
Sotera Health Company | 1.08B |
Neogen | 929.24M |
Guardant Health | 603.73M |
Corcept Therapeutics | 523.53M |
iRhythm Technologies | 513.17M |
Axonics | 387.14M |
Alvotech | 114.39M |
PBH News
- 9 hours ago - Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results - GlobeNewsWire
- 26 days ago - Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference - GlobeNewsWire
- 7 weeks ago - Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results - GlobeNewsWire
- 2 months ago - Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results - GlobeNewsWire
- 3 months ago - Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag - GlobeNewsWire
- 5 months ago - Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results - GlobeNewsWire
- 5 months ago - Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene - GlobeNewsWire
- 6 months ago - Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results - GlobeNewsWire